PAR 0.00% 23.5¢ paradigm biopharmaceuticals limited..

Ann: Quarterly Activities/Appendix 4C Cash Flow Report, page-12

  1. 9,638 Posts.
    lightbulb Created with Sketch. 1229
    :....."Forecast cash outflow for the March 2024 quarter is expected to be $8 - $11m (including R&D refund) and the June 2024 quarter expected to be in the $6m - $8m range which is inclusive of phase 3 stage 2 restart costs."

    Regional deal will be only way to get PARO over the line now.


 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
(20min delay)
Last
23.5¢
Change
0.000(0.00%)
Mkt cap ! $82.20M
Open High Low Value Volume
24.0¢ 24.0¢ 23.5¢ $71.76K 304.2K

Buyers (Bids)

No. Vol. Price($)
5 138370 23.5¢
 

Sellers (Offers)

Price($) Vol. No.
24.0¢ 73129 3
View Market Depth
Last trade - 16.10pm 18/06/2024 (20 minute delay) ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.